FSMAX
Price
$92.17
Change
+$1.25 (+1.37%)
Updated
Jun 26 closing price
Net Assets
37.61B
JACNX
Price
$28.50
Change
+$0.39 (+1.39%)
Updated
Jun 26 closing price
Net Assets
4.42B
Interact to see
Advertisement

FSMAX vs JACNX

Header iconFSMAX vs JACNX Comparison
Open Charts FSMAX vs JACNXBanner chart's image
Fidelity Extended Market Index
Price$92.17
Change+$1.25 (+1.37%)
VolumeN/A
Net Assets37.61B
Janus Henderson Contrarian D
Price$28.50
Change+$0.39 (+1.39%)
VolumeN/A
Net Assets4.42B
FSMAX vs JACNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. JACNX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and JACNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 37.6B vs. JACNX (4.43B). FSMAX pays higher dividends than JACNX: FSMAX (0.50) vs JACNX (0.44). FSMAX was incepted earlier than JACNX: FSMAX (14 years) vs JACNX (25 years). JACNX (0.64) is less costly to investors than FSMAX (0.04). JACNX is a more actively managed with annual turnover of: 42.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than JACNX: FSMAX (0) vs JACNX (2500). FSMAX annual gain was more profitable for investors over the last year : 14.57 vs. JACNX (4.67). FSMAX return over 5 years is better than : 64.38 vs. JACNX (48.27).
FSMAXJACNXFSMAX / JACNX
Total Expense Ratio0.040.645%
Annual Report Gross Expense Ratio0.040.645%
Fund Existence14 years25 years-
Gain YTD0.0442.8882%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets37.6B4.43B850%
Annual Yield % from dividends0.500.44112%
Returns for 1 year14.574.67312%
Returns for 3 years43.6922.47194%
Returns for 5 years64.3848.27133%
Returns for 10 years73.7945.21163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERHSX13.91N/A
N/A
Eaton Vance Worldwide Health Sci R
VAFRX28.41N/A
N/A
Invesco American Franchise R
HRLAX9.19N/A
N/A
Hartford Real Asset A
GOFFX49.92N/A
N/A
Invesco Global Opportunities R5
EARAX14.88N/A
N/A
Eaton Vance RBA All Asset Strategy Fd A